Tellgen Corporation
300642
Rangering i aksjer
#13493
Tellgen Corporation is dedicated to the creation, manufacturing, and supply of... Tellgen Corporation is dedicated to the creation, manufacturing, and supply of in-vitro diagnostic (IVD) solutions, serving both the Chinese domestic market and a global clientele. Their extensive product catalog includes cancer detection markers, test kits for human papilloma virus (HPV), ToRCH diagnostic assays, Y-chromosome microdeletion screening kits, and sophisticated multiplex immunoassay systems. The company, founded in 2003, operates from its headquarters in Shanghai, China.
Aksjekurs
$2.87
Markedsverdi
$465.09M
Endring (1 dag)
7.08%
Endring (1 år)
-23.69%
Land
CN
Handel Tellgen Corporation (300642)
Kategori
Healthcare
Historikk for aksjesplitt for Tellgen Corporation (300642)
Aksjen Tellgen Corporation (symbol: 300642) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Oct 21, 2026.
Én 300642-aksje kjøpt før Oct 21, 2026 tilsvarer i dag 0 300642-aksjer.
Den nyeste splittelsen skjedde Oct 21, 2026.
Én 300642-aksje kjøpt før Oct 21, 2026 tilsvarer i dag 0 300642-aksjer.
Liste over aksjesplitt
| År | Splitt | Multiplikator | Kumulativ multiplikator |
|---|---|---|---|
| Ikke nok data for de angitte datoene. | |||
Aksjesplitt for lignende selskaper eller konkurrenter
| Selskap | Antall aksjesplitt | Kumulativ multiplikator | Land |
|---|---|---|---|
| 9 | x285 |
US
|
|
| 7 | x127 |
IE
|
|
| 9 | x162 |
US
|
|
| 2 | x4 |
US
|
|
| 0 | - |
DE
|
